UnitedHealthcare
Gazyva (obinutuzumab)
Drugs for Cancer : Drugs for Cancer
  • Chronic Lymphocytic Leukemia:
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Hematologist;Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Drug Policy Based On: Payer Specific
    Concomitant Therapy Requirement: chlorambucil
    Diagnosis Types: Previously untreated CLL

  • Prior Authorization: Chronic Lymphocytic Leukemia:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes